Your browser doesn't support javascript.
loading
Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era.
Berry, Jesse L; Shah, Sona; Bechtold, Mercy; Zolfaghari, Emily; Jubran, Rima; Kim, Jonathan W.
Affiliation
  • Berry JL; USC Roski Eye Institute, Los Angeles, California.
  • Shah S; The Vision Center at Children's Hospital Los Angeles, Los Angeles, California.
  • Bechtold M; USC Roski Eye Institute, Los Angeles, California.
  • Zolfaghari E; The Vision Center at Children's Hospital Los Angeles, Los Angeles, California.
  • Jubran R; USC Roski Eye Institute, Los Angeles, California.
  • Kim JW; The Vision Center at Children's Hospital Los Angeles, Los Angeles, California.
Pediatr Blood Cancer ; 64(12)2017 Dec.
Article in En | MEDLINE | ID: mdl-28646513

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retinoblastoma / Antineoplastic Agents, Alkylating / Retinal Neoplasms / Melphalan Type of study: Observational_studies Limits: Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2017 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retinoblastoma / Antineoplastic Agents, Alkylating / Retinal Neoplasms / Melphalan Type of study: Observational_studies Limits: Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2017 Document type: Article Country of publication: